A review of MIMS device eye treatment
Part of Eyes & vision clinical trials.
This study is a retrospective chart review looking at eyes that received treatment with the MIMS device. It helps doctors understand how this treatment worked in the past.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had the MIMS device used on one eye without any other procedures at the same time.
- Your MIMS surgery happened between September 27, 2023 and April 30, 2024.
- This is a review of past records, so no new visits or tests are needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is checking on people who had a specific eye surgery called MIMS at least two years ago. It aims to see how they are doing over time.
This study tests a new minimally-invasive surgery called MIMS to lower eye pressure in people with open-angle glaucoma that isn't well controlled even with multiple eye drop medications. The surgery makes a tiny opening to help fluid drain and reduce pressure in the eye.
This trial looks at how well certain surgical systems work when combined with cataract surgery and a glaucoma procedure. It may help people with glaucoma who need fewer medications after surgery.
This trial studies a new treatment (a tiny device called iStent Infinite and a medication implant) for people with moderate to severe open-angle glaucoma who have not responded well to drops or laser. The goal is to see if this treatment can lower eye pressure and help avoid traditional surgery.
This trial tests a tiny implant called MINIject S+ to lower eye pressure in people with open angle glaucoma that isn't well controlled with eye drops. It may be done alone or with cataract surgery.
This trial studies outcomes after certain minimally invasive glaucoma surgeries, including the Preserflo microshunt. It may help improve how safely and effectively glaucoma surgery is done, and how patients are followed afterward.
Hear when a new Open Angle Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.